BioAge Labs, Inc. is a clinical-stage biopharmaceutical company specializing in the development ... BioAge announced that it discontinued its STRIDES Phase 2 trial for azelaprag, citing safety ...
( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Dec. 22, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BioAge Labs, Inc. (NASDAQ: BIOA) ...
NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into BioAge Labs, Inc. (NASDAQ:BIOA) for potential violations of the ...